The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis

Aims The aim of the present meta‐analysis was to evaluate the efficacy and safety of fingolimod in patients with relapsing multiple sclerosis (RMS). Methods PubMed, Embase, the Cochrane Library and ClinicalTrials.gov were searched for relevant studies. Two authors independently selected the studies, assessed the risk of bias, and extracted the data. The meta‐analysis was performed in RevMan 5.3 provided by the Cochrane Collaboration. Results Ten...